nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—HTR7—vas deferens—urinary bladder cancer	0.263	0.488	CbGeAlD
Molindone—HTR2A—urine—urinary bladder cancer	0.0408	0.0757	CbGeAlD
Molindone—Pigmentation disorder—Thiotepa—urinary bladder cancer	0.0304	0.0657	CcSEcCtD
Molindone—CHRM1—prostate gland—urinary bladder cancer	0.0275	0.0512	CbGeAlD
Molindone—Pigmentation disorder—Etoposide—urinary bladder cancer	0.0218	0.0472	CcSEcCtD
Molindone—Urinary retention—Valrubicin—urinary bladder cancer	0.0202	0.0437	CcSEcCtD
Molindone—HTR7—epithelium—urinary bladder cancer	0.0172	0.032	CbGeAlD
Molindone—ADRA2A—prostate gland—urinary bladder cancer	0.0172	0.032	CbGeAlD
Molindone—HTR1A—renal system—urinary bladder cancer	0.0167	0.0311	CbGeAlD
Molindone—HTR7—smooth muscle tissue—urinary bladder cancer	0.0166	0.0309	CbGeAlD
Molindone—HTR7—renal system—urinary bladder cancer	0.016	0.0297	CbGeAlD
Molindone—CHRM1—female reproductive system—urinary bladder cancer	0.015	0.0279	CbGeAlD
Molindone—Throat tightness—Etoposide—urinary bladder cancer	0.0148	0.0321	CcSEcCtD
Molindone—ADRA2A—seminal vesicle—urinary bladder cancer	0.0146	0.027	CbGeAlD
Molindone—Extrapyramidal disorder—Thiotepa—urinary bladder cancer	0.0135	0.0291	CcSEcCtD
Molindone—HTR7—female reproductive system—urinary bladder cancer	0.0128	0.0238	CbGeAlD
Molindone—Pigmentation disorder—Epirubicin—urinary bladder cancer	0.0122	0.0265	CcSEcCtD
Molindone—Amenorrhoea—Thiotepa—urinary bladder cancer	0.0115	0.025	CcSEcCtD
Molindone—ADRA2A—urethra—urinary bladder cancer	0.0115	0.0214	CbGeAlD
Molindone—Pigmentation disorder—Doxorubicin—urinary bladder cancer	0.0113	0.0245	CcSEcCtD
Molindone—Drowsiness—Mitomycin—urinary bladder cancer	0.0113	0.0244	CcSEcCtD
Molindone—HTR2A—epithelium—urinary bladder cancer	0.0108	0.02	CbGeAlD
Molindone—HTR2A—smooth muscle tissue—urinary bladder cancer	0.0104	0.0192	CbGeAlD
Molindone—HTR2A—renal system—urinary bladder cancer	0.00997	0.0185	CbGeAlD
Molindone—ADRA2A—female reproductive system—urinary bladder cancer	0.00939	0.0174	CbGeAlD
Molindone—Leukocytosis—Fluorouracil—urinary bladder cancer	0.00892	0.0193	CcSEcCtD
Molindone—ADRA2A—vagina—urinary bladder cancer	0.00849	0.0158	CbGeAlD
Molindone—Vision blurred—Mitomycin—urinary bladder cancer	0.0083	0.018	CcSEcCtD
Molindone—HTR2A—female reproductive system—urinary bladder cancer	0.00799	0.0148	CbGeAlD
Molindone—Leukopenia—Mitomycin—urinary bladder cancer	0.00788	0.0171	CcSEcCtD
Molindone—HTR2A—vagina—urinary bladder cancer	0.00722	0.0134	CbGeAlD
Molindone—Euphoric mood—Fluorouracil—urinary bladder cancer	0.0072	0.0156	CcSEcCtD
Molindone—Urinary retention—Thiotepa—urinary bladder cancer	0.00699	0.0151	CcSEcCtD
Molindone—Rash—Valrubicin—urinary bladder cancer	0.00658	0.0142	CcSEcCtD
Molindone—Dermatitis—Valrubicin—urinary bladder cancer	0.00657	0.0142	CcSEcCtD
Molindone—Dyspnoea—Mitomycin—urinary bladder cancer	0.00641	0.0139	CcSEcCtD
Molindone—Somnolence—Mitomycin—urinary bladder cancer	0.00639	0.0138	CcSEcCtD
Molindone—Nausea—Valrubicin—urinary bladder cancer	0.0062	0.0134	CcSEcCtD
Molindone—Weight increased—Thiotepa—urinary bladder cancer	0.00579	0.0125	CcSEcCtD
Molindone—ADRA2A—lymph node—urinary bladder cancer	0.00549	0.0102	CbGeAlD
Molindone—Dysphagia—Fluorouracil—urinary bladder cancer	0.00526	0.0114	CcSEcCtD
Molindone—Amenorrhoea—Epirubicin—urinary bladder cancer	0.00464	0.0101	CcSEcCtD
Molindone—Dysphagia—Etoposide—urinary bladder cancer	0.00457	0.00989	CcSEcCtD
Molindone—Rash—Mitomycin—urinary bladder cancer	0.00453	0.00982	CcSEcCtD
Molindone—Dermatitis—Mitomycin—urinary bladder cancer	0.00453	0.00981	CcSEcCtD
Molindone—Dyskinesia—Epirubicin—urinary bladder cancer	0.00434	0.0094	CcSEcCtD
Molindone—Amenorrhoea—Doxorubicin—urinary bladder cancer	0.0043	0.00931	CcSEcCtD
Molindone—Nausea—Mitomycin—urinary bladder cancer	0.00427	0.00925	CcSEcCtD
Molindone—Vision blurred—Thiotepa—urinary bladder cancer	0.00417	0.00904	CcSEcCtD
Molindone—Agitation—Thiotepa—urinary bladder cancer	0.00407	0.00882	CcSEcCtD
Molindone—Dyskinesia—Doxorubicin—urinary bladder cancer	0.00402	0.0087	CcSEcCtD
Molindone—Leukopenia—Thiotepa—urinary bladder cancer	0.00396	0.00859	CcSEcCtD
Molindone—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.00396	0.00858	CcSEcCtD
Molindone—Gynaecomastia—Methotrexate—urinary bladder cancer	0.0039	0.00845	CcSEcCtD
Molindone—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.00367	0.00794	CcSEcCtD
Molindone—Tachycardia—Thiotepa—urinary bladder cancer	0.00353	0.00764	CcSEcCtD
Molindone—Vision blurred—Fluorouracil—urinary bladder cancer	0.00345	0.00748	CcSEcCtD
Molindone—Muscle spasms—Cisplatin—urinary bladder cancer	0.00334	0.00723	CcSEcCtD
Molindone—Leukopenia—Gemcitabine—urinary bladder cancer	0.00334	0.00722	CcSEcCtD
Molindone—Leukopenia—Fluorouracil—urinary bladder cancer	0.00328	0.0071	CcSEcCtD
Molindone—Vision blurred—Cisplatin—urinary bladder cancer	0.00327	0.00709	CcSEcCtD
Molindone—Tremor—Cisplatin—urinary bladder cancer	0.00325	0.00705	CcSEcCtD
Molindone—Somnolence—Thiotepa—urinary bladder cancer	0.00321	0.00696	CcSEcCtD
Molindone—Leukopenia—Cisplatin—urinary bladder cancer	0.00311	0.00673	CcSEcCtD
Molindone—Constipation—Thiotepa—urinary bladder cancer	0.00309	0.0067	CcSEcCtD
Molindone—Muscle spasms—Etoposide—urinary bladder cancer	0.00306	0.00663	CcSEcCtD
Molindone—Tachycardia—Fluorouracil—urinary bladder cancer	0.00292	0.00632	CcSEcCtD
Molindone—Leukopenia—Etoposide—urinary bladder cancer	0.00285	0.00617	CcSEcCtD
Molindone—Hypotension—Gemcitabine—urinary bladder cancer	0.00284	0.00615	CcSEcCtD
Molindone—Hypotension—Fluorouracil—urinary bladder cancer	0.00279	0.00605	CcSEcCtD
Molindone—Tachycardia—Cisplatin—urinary bladder cancer	0.00277	0.00599	CcSEcCtD
Molindone—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00271	0.00587	CcSEcCtD
Molindone—Somnolence—Gemcitabine—urinary bladder cancer	0.0027	0.00586	CcSEcCtD
Molindone—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00267	0.00577	CcSEcCtD
Molindone—Somnolence—Fluorouracil—urinary bladder cancer	0.00266	0.00576	CcSEcCtD
Molindone—Hypotension—Cisplatin—urinary bladder cancer	0.00265	0.00574	CcSEcCtD
Molindone—Constipation—Gemcitabine—urinary bladder cancer	0.0026	0.00563	CcSEcCtD
Molindone—Dysphagia—Epirubicin—urinary bladder cancer	0.00256	0.00554	CcSEcCtD
Molindone—Tachycardia—Etoposide—urinary bladder cancer	0.00253	0.00549	CcSEcCtD
Molindone—Dyspnoea—Cisplatin—urinary bladder cancer	0.00253	0.00547	CcSEcCtD
Molindone—Drowsiness—Methotrexate—urinary bladder cancer	0.00244	0.00528	CcSEcCtD
Molindone—Hypotension—Etoposide—urinary bladder cancer	0.00243	0.00526	CcSEcCtD
Molindone—Dysphagia—Doxorubicin—urinary bladder cancer	0.00237	0.00513	CcSEcCtD
Molindone—Weight increased—Epirubicin—urinary bladder cancer	0.00233	0.00505	CcSEcCtD
Molindone—Weight decreased—Epirubicin—urinary bladder cancer	0.00232	0.00502	CcSEcCtD
Molindone—Dyspnoea—Etoposide—urinary bladder cancer	0.00232	0.00501	CcSEcCtD
Molindone—Somnolence—Etoposide—urinary bladder cancer	0.00231	0.005	CcSEcCtD
Molindone—Drowsiness—Epirubicin—urinary bladder cancer	0.00228	0.00494	CcSEcCtD
Molindone—Rash—Thiotepa—urinary bladder cancer	0.00228	0.00494	CcSEcCtD
Molindone—Dermatitis—Thiotepa—urinary bladder cancer	0.00228	0.00493	CcSEcCtD
Molindone—Constipation—Etoposide—urinary bladder cancer	0.00222	0.00481	CcSEcCtD
Molindone—Weight increased—Doxorubicin—urinary bladder cancer	0.00216	0.00467	CcSEcCtD
Molindone—Nausea—Thiotepa—urinary bladder cancer	0.00215	0.00465	CcSEcCtD
Molindone—Weight decreased—Doxorubicin—urinary bladder cancer	0.00214	0.00464	CcSEcCtD
Molindone—Drowsiness—Doxorubicin—urinary bladder cancer	0.00211	0.00457	CcSEcCtD
Molindone—Rash—Gemcitabine—urinary bladder cancer	0.00192	0.00415	CcSEcCtD
Molindone—Dermatitis—Gemcitabine—urinary bladder cancer	0.00192	0.00415	CcSEcCtD
Molindone—Rash—Fluorouracil—urinary bladder cancer	0.00189	0.00408	CcSEcCtD
Molindone—Dermatitis—Fluorouracil—urinary bladder cancer	0.00188	0.00408	CcSEcCtD
Molindone—Nausea—Gemcitabine—urinary bladder cancer	0.00181	0.00391	CcSEcCtD
Molindone—Vision blurred—Methotrexate—urinary bladder cancer	0.0018	0.00389	CcSEcCtD
Molindone—Rash—Cisplatin—urinary bladder cancer	0.00179	0.00387	CcSEcCtD
Molindone—Dermatitis—Cisplatin—urinary bladder cancer	0.00179	0.00387	CcSEcCtD
Molindone—Nausea—Fluorouracil—urinary bladder cancer	0.00178	0.00385	CcSEcCtD
Molindone—Muscle spasms—Epirubicin—urinary bladder cancer	0.00171	0.00371	CcSEcCtD
Molindone—Leukopenia—Methotrexate—urinary bladder cancer	0.00171	0.0037	CcSEcCtD
Molindone—Nausea—Cisplatin—urinary bladder cancer	0.00168	0.00365	CcSEcCtD
Molindone—Vision blurred—Epirubicin—urinary bladder cancer	0.00168	0.00364	CcSEcCtD
Molindone—Agitation—Epirubicin—urinary bladder cancer	0.00164	0.00355	CcSEcCtD
Molindone—Rash—Etoposide—urinary bladder cancer	0.00164	0.00355	CcSEcCtD
Molindone—Dermatitis—Etoposide—urinary bladder cancer	0.00164	0.00354	CcSEcCtD
Molindone—Leukopenia—Epirubicin—urinary bladder cancer	0.0016	0.00346	CcSEcCtD
Molindone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00159	0.00344	CcSEcCtD
Molindone—Vision blurred—Doxorubicin—urinary bladder cancer	0.00156	0.00337	CcSEcCtD
Molindone—Nausea—Etoposide—urinary bladder cancer	0.00154	0.00334	CcSEcCtD
Molindone—Agitation—Doxorubicin—urinary bladder cancer	0.00152	0.00328	CcSEcCtD
Molindone—Dry mouth—Epirubicin—urinary bladder cancer	0.00148	0.00322	CcSEcCtD
Molindone—Leukopenia—Doxorubicin—urinary bladder cancer	0.00148	0.0032	CcSEcCtD
Molindone—Hypotension—Methotrexate—urinary bladder cancer	0.00145	0.00315	CcSEcCtD
Molindone—Tachycardia—Epirubicin—urinary bladder cancer	0.00142	0.00308	CcSEcCtD
Molindone—Dyspnoea—Methotrexate—urinary bladder cancer	0.00139	0.003	CcSEcCtD
Molindone—Somnolence—Methotrexate—urinary bladder cancer	0.00138	0.003	CcSEcCtD
Molindone—Dry mouth—Doxorubicin—urinary bladder cancer	0.00137	0.00298	CcSEcCtD
Molindone—Hypotension—Epirubicin—urinary bladder cancer	0.00136	0.00295	CcSEcCtD
Molindone—Tachycardia—Doxorubicin—urinary bladder cancer	0.00131	0.00285	CcSEcCtD
Molindone—Dyspnoea—Epirubicin—urinary bladder cancer	0.0013	0.00281	CcSEcCtD
Molindone—Somnolence—Epirubicin—urinary bladder cancer	0.00129	0.0028	CcSEcCtD
Molindone—Hypotension—Doxorubicin—urinary bladder cancer	0.00126	0.00273	CcSEcCtD
Molindone—Constipation—Epirubicin—urinary bladder cancer	0.00124	0.0027	CcSEcCtD
Molindone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.0012	0.0026	CcSEcCtD
Molindone—Somnolence—Doxorubicin—urinary bladder cancer	0.0012	0.00259	CcSEcCtD
Molindone—Constipation—Doxorubicin—urinary bladder cancer	0.00115	0.00249	CcSEcCtD
Molindone—Rash—Methotrexate—urinary bladder cancer	0.000981	0.00212	CcSEcCtD
Molindone—Dermatitis—Methotrexate—urinary bladder cancer	0.00098	0.00212	CcSEcCtD
Molindone—Nausea—Methotrexate—urinary bladder cancer	0.000924	0.002	CcSEcCtD
Molindone—Rash—Epirubicin—urinary bladder cancer	0.000918	0.00199	CcSEcCtD
Molindone—Dermatitis—Epirubicin—urinary bladder cancer	0.000917	0.00199	CcSEcCtD
Molindone—Nausea—Epirubicin—urinary bladder cancer	0.000865	0.00187	CcSEcCtD
Molindone—Rash—Doxorubicin—urinary bladder cancer	0.000849	0.00184	CcSEcCtD
Molindone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000848	0.00184	CcSEcCtD
Molindone—Nausea—Doxorubicin—urinary bladder cancer	0.0008	0.00173	CcSEcCtD
